Oroxylin A Suppresses the Cell Proliferation, Migration, and EMT via NF-κB Signaling Pathway in Human Breast Cancer Cells
Joint Authors
Sun, XiaoHu
Chang, Xinzhong
Wang, Yunhua
Xu, Boyang
Cao, Xuchen
Source
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-10, 10 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-06-23
Country of Publication
Egypt
No. of Pages
10
Main Subjects
Abstract EN
Oroxylin A is a natural extract and has been reported to have a remarkable anticancer function.
However, the mechanism of its anticancer activity remains not quite clear.
In this study, we examined the inhibiting effects of Oroxylin A on breast cancer cell proliferation, migration, and epithelial-mesenchymal transition (EMT) and its possible molecular mechanism.
The cytoactive and inflammatory factors were analyzed via Cell Counting Kit-8 assay and ELISA assay, respectively.
Flow cytometry and western blotting were used to assess the cell proliferation.
In addition, a wound healing assay and transwell assay were used to detect cell invasion and migration.
qRT-PCR and western blot were employed to determine the effect of Oroxylin A on the EMT formation.
Moreover, expression level of protein related to NF-κB signaling pathway was determined by western blot.
The results revealed that Oroxylin A attenuated the cytoactivity of MDA-MB-231 cells in a dose- and a time-dependent manner.
Moreover, cell proliferation, invasion, and migration of breast cancer cells were inhibited by Oroxylin A compared to the control.
The mRNA and protein expression levels of E-cadherin were remarkably increased while N-cadherin and Vimentin remarkably decreased.
Besides, Oroxylin A suppressed the expression of inflammatory factors and NF-κB activation.
Furthermore, we also found that supplement of TNF-α reversed the effects of Oroxylin A on the cell proliferation, invasion, migration, and EMT in breast cancer cells.
Taken together, our results suggested that Oroxylin A inhibited the cell proliferation, invasion, migration, and EMT through inactivating NF-κB signaling pathway in human breast cancer cells.
These findings strongly suggest that Oroxylin A could be a therapeutic potential candidate for the treatment of breast cancer.
American Psychological Association (APA)
Sun, XiaoHu& Chang, Xinzhong& Wang, Yunhua& Xu, Boyang& Cao, Xuchen. 2019. Oroxylin A Suppresses the Cell Proliferation, Migration, and EMT via NF-κB Signaling Pathway in Human Breast Cancer Cells. BioMed Research International،Vol. 2019, no. 2019, pp.1-10.
https://search.emarefa.net/detail/BIM-1128402
Modern Language Association (MLA)
Sun, XiaoHu…[et al.]. Oroxylin A Suppresses the Cell Proliferation, Migration, and EMT via NF-κB Signaling Pathway in Human Breast Cancer Cells. BioMed Research International No. 2019 (2019), pp.1-10.
https://search.emarefa.net/detail/BIM-1128402
American Medical Association (AMA)
Sun, XiaoHu& Chang, Xinzhong& Wang, Yunhua& Xu, Boyang& Cao, Xuchen. Oroxylin A Suppresses the Cell Proliferation, Migration, and EMT via NF-κB Signaling Pathway in Human Breast Cancer Cells. BioMed Research International. 2019. Vol. 2019, no. 2019, pp.1-10.
https://search.emarefa.net/detail/BIM-1128402
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1128402